Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1995 August; 88(8): 433–436.
PMCID: PMC1295295

Anticardiolipin antibodies and cardiovascular disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (776K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hughes GR, Khamashta MA. The antiphospholipid syndrome. J R Coll Physicians Lond. 1994 Jul-Aug;28(4):301–304. [PubMed]
  • MUELLER JF, RATNOFF O, HEINLE RW. Observations on the characteristics of an unusual circulating anticoagulant. J Lab Clin Med. 1951 Aug;38(2):254–261. [PubMed]
  • Triplett DA. Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause? Arch Pathol Lab Med. 1993 Jan;117(1):78–88. [PubMed]
  • Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987 Sep;69(3):557–565. [PubMed]
  • Muir KW, Squire IB, Alwan W, Lees KR. Anticardiolipin antibodies in an unselected stroke population. Lancet. 1994 Aug 13;344(8920):452–456. [PubMed]
  • Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 Nov 26;2(8361):1211–1214. [PubMed]
  • Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990 May 1;112(9):682–698. [PubMed]
  • Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med. 1990 Oct;89(4):411–419. [PubMed]
  • Cervera R, Font J, Paré C, Azqueta M, Pérez-Villa F, López-Soto A, Ingelmo M. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis. 1992 Feb;51(2):156–159. [PMC free article] [PubMed]
  • Khamashta MA, Hughes GR. Antiphospholipid antibodies and valve disease in patients with systemic lupus erythematosus. J Am Coll Cardiol. 1993 Oct;22(4):1269–1270. [PubMed]
  • Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population. Medicine (Baltimore) 1992 Jul;71(4):216–223. [PubMed]
  • Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992 Aug 15;117(4):303–308. [PubMed]
  • Asherson RA, Baguley E, Pal C, Hughes GR. Antiphospholipid syndrome: five year follow up. Ann Rheum Dis. 1991 Nov;50(11):805–810. [PMC free article] [PubMed]
  • Jonas J, Kölble K, Völcker HE, Kalden JR. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol. 1986 Jul 15;102(1):37–40. [PubMed]
  • Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med. 1992 Feb 15;116(4):293–298. [PubMed]
  • Hamsten A, Norberg R, Björkholm M, de Faire U, Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986 Jan 18;1(8473):113–116. [PubMed]
  • Phadke KV, Phillips RA, Clarke DT, Jones M, Naish P, Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J. 1993 May;69(5):391–394. [PMC free article] [PubMed]
  • Sletnes KE, Smith P, Abdelnoor M, Arnesen H, Wisløff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet. 1992 Feb 22;339(8791):451–453. [PubMed]
  • Barbut D, Borer JS, Gharavi A, Wallerson D, Devereux RB, Supino P, Suite ND. Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events. Am J Cardiol. 1992 Oct 1;70(9):901–905. [PubMed]
  • Taylor LM, Jr, Chitwood RW, Dalman RL, Sexton G, Goodnight SH, Porter JM. Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study. Ann Surg. 1994 Oct;220(4):544–551. [PubMed]
  • Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992 Dec 15;117(12):997–1002. [PubMed]
  • Kapiotis S, Speiser W, Pabinger-Fasching I, Kyrle PA, Lechner K. Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis. 1991;21(1):19–24. [PubMed]
  • Czlonkowska A, Meurer M, Palasik W, Baranska-Gieruszczak M, Mendel T, Wierzchowska E. Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population? Acta Neurol Scand. 1992 Sep;86(3):304–307. [PubMed]
  • Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke. 1992 Feb;23(2):189–193. [PubMed]
  • Montalbán J, Codina A, Ordi J, Vilardell M, Khamashta MA, Hughes GR. Antiphospholipid antibodies in cerebral ischemia. Stroke. 1991 Jun;22(6):750–753. [PubMed]
  • Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology. 1990 Aug;40(8):1190–1196. [PubMed]
  • Hess DC, Krauss J, Adams RJ, Nichols FT, Zhang D, Rountree HA. Anticardiolipin antibodies: a study of frequency in TIA and stroke. Neurology. 1991 Apr;41(4):525–528. [PubMed]
  • Trimble M, Bell DA, Brien W, Hachinski V, O'Keefe B, McLay C, Black J. The antiphospholipid syndrome: prevalence among patients with stroke and transient ischemic attacks. Am J Med. 1990 Jun;88(6):593–597. [PubMed]
  • Kushner MJ. Prospective study of anticardiolipin antibodies in stroke. Stroke. 1990 Feb;21(2):295–298. [PubMed]
  • Ching LM, Joseph WR, Baguley BC. Effect of tumour growth on the macrophage response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid. Anticancer Res. 1993 Nov-Dec;13(6A):2069–2075. [PubMed]
  • Ackerman RH. Of cerebral blood flow, stroke and SPECT. Stroke. 1984 Jan-Feb;15(1):1–4. [PubMed]
  • Klemp P, Cooper RC, Strauss FJ, Jordaan ER, Przybojewski JZ, Nel N. Anti-cardiolipin antibodies in ischaemic heart disease. Clin Exp Immunol. 1988 Nov;74(2):254–257. [PubMed]
  • Lecerf V, Alhenc-Gelas M, Laurian C, Bruneval P, Aiach M, Cormier JM, Fiessinger JN. Antiphospholipid antibodies and atherosclerosis. Am J Med. 1992 May;92(5):575–576. [PubMed]
  • Morton KE, Gavaghan TP, Krilis SA, Daggard GE, Baron DW, Hickie JB, Chesterman CN. Coronary artery bypass graft failure--an autoimmune phenomenon? Lancet. 1986 Dec 13;2(8520):1353–1357. [PubMed]
  • Eber B, Schumacher M, Auer-Grumbach P, Toplak H, Klein W. Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1992 May 15;69(16):1255–1258. [PubMed]
  • Tsakiris DA, Marbet GA, Burkart F, Duckert F. Anticardiolipin antibodies and coronary heart disease. Eur Heart J. 1992 Dec;13(12):1645–1648. [PubMed]
  • Eber B, Kronberger-Schaffer E, Brussee H, Klima G, Obernosterer A, Toporsch M, Dusleag J, Klein W. Anticardiolipin antibodies are no marker for survived myocardial infarction. Klin Wochenschr. 1990 Jun 19;68(12):594–596. [PubMed]
  • Hendra TJ, Baguley E, Harris EN, Khamashta MH, Trembath RC, Hughes GR, Yudkin JS. Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease. Postgrad Med J. 1989 Mar;65(761):140–143. [PMC free article] [PubMed]
  • Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet. 1993 Apr 10;341(8850):923–925. [PubMed]
  • Cervera R, Khamashta MA, Font J, Ramírez G, D'Cruz D, Montalbán J, López-Soto A, Asherson RA, Ingelmo M, Hughes GR. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity. 1991;11(1):1–6. [PubMed]
  • Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta M, Hughes GR, Zanussi C, Balestrieri G, et al. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1988 Nov;74(2):247–253. [PubMed]
  • Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol. 1989 Aug;161(2):369–373. [PubMed]
  • Vlachoyiannopoulos PG, Tsiakou E, Chalevelakis G, Raptis SA, Moutsopoulos HM. Antiphospholipid syndrome: clinical and therapeutic aspects. Lupus. 1994 Apr;3(2):91–96. [PubMed]
  • Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol. 1989 Feb;160(2):439–443. [PubMed]
  • Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol. 1993 Dec;169(6):1411–1417. [PubMed]
  • al-Momen AK, Moghraby SA, el-Rab MO, Gader AM, al-Balla SR, al-Meshari AA, al-Nuaim L. Pregnancy outcome in women with antiphospholipid antibodies. Clin Rheumatol. 1993 Sep;12(3):381–386. [PubMed]
  • Derksen RH, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis. 1993 Sep;52(9):689–692. [PMC free article] [PubMed]
  • Rivier G, Herranz MT, Khamashta MA, Hughes GR. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus. 1994 Apr;3(2):85–90. [PubMed]
  • HILL AB. THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med. 1965 May;58:295–300. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press